10x Genomics, Inc. (TXG)

19.65 -0.37 (-1.85%) As of 10:12AM EDT. Market open.

10x Genomics, Inc.

6230 Stoneridge Mall Road
Pleasanton, CA 94588-3260
United States
925 401 7300
https://www.10xgenomics.com

Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 1,259

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Serge Saxonov Ph.D.	Co-Founder, CEO & Director	925.05k	1.98M	1977
Dr. Benjamin J. Hindson Ph.D.	Co-Founder, President, Chief Scientific Officer & Director	618.32k	1.5M	1975
Mr. Eric S. Whitaker Esq.	Chief Legal Officer	615.38k	3.19M	1967
Mr. Jim Goodrich	Chief of Global Operations	N/A	N/A	N/A
Mr. Michael Schnall-Levin	Founding Scientist & CTO	N/A	N/A	N/A
Ms. Cassie Corneau	Manager of Investor Relations and Strategic Finance	N/A	N/A	N/A
Ms. Rebecca Port	Chief People Officer	N/A	N/A	N/A
Mr. Jens Durruthy	Associate Director of Product Management	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Corporate governance

10x Genomics, Inc.’s ISS governance QualityScore as of 1 October 2024 is 8. The pillar scores are Audit: 3; Board: 6; Shareholder rights: 10; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.